Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study
Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women
Patients Prefer Silicone Over Saline Implants
More Breast Cancer Patients Opt To Remove Both Breasts
Small Study: Radiation, Chemo May Better Control Anal Cancer
BRAF Inhibitor Shrank Tumors In Phase II Genentech Study
Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer
Radiotherapy Plus Cetuximab May Control Head/Neck Cancer
Clinical Trials Approved By NCI
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
